By a few weeks. Is it a big deal?
I don’t see how it is embarrassing in any way.
Antigen is just one part of AT1’s business. It might take them a little time to make applications, at the cost of developing their whole business. 3 new patents, HIV, Febridx, OHM, a lot more going on.
I’m fine with a later approval than Patonic that if it means they have a diversified income stream.
Media Update, page-1246
-
- There are more pages in this discussion • 600 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $17.25M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.7¢ | $6.093K | 217.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 900590 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 472024 | 8 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |